Suppressive effect of calcipotriol on the induction of matrix metalloproteinase (MMP)-9 and MMP-13 in a human squamous cell carcinoma cell line

Clinical and Experimental Dermatology

Volumn 37, Issue 8, 2012, Pages 889-896

  Meephansan, J ^a   Komine, M ^a   Tsuda, H ^a   Ohtsuki, M ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; COLLAGENASE 3; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; CALCITRIOL; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870065090     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2012.04381.x     Document Type: Article

References (24)

1. Bergers G, Brekken R, McMahon G et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2: 737-44.
2. Kupferman ME, Fini ME, Muller WJ et al. Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol 2000; 157: 1777-83.
3. la-aho R, Ahonen M, George SJ et al. Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo. Oncogene 2004; 23: 5111-23.
4. Johansson N, Airola K, Grenman R et al. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 1997; 151: 499-508.
5. Airola K, Johansson N, Kariniemi AL et al. Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol 1997; 109: 225-31.
6. Vaalamo M, Mattila L, Johansson N et al. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol 1997; 109: 96-101.
7. Schwartz GG, Wang MH, Zang M et al. 1 alpha,25- Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev 1997; 6: 727-32.
8. Koli K, Keski-Oja J. 1 alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 2000; 11: 221-9.
9. Majewski S, Skopinska M, Marczak M et al. Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis. J Invest Dermatol Symp Proc 1996; 1: 97-101.
10. Mantell DJ, Owens PE, Bundred NJ et al. 1 alpha,25- dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 2000; 87: 214-20.
11. Koli K, Keski-Oja J. Vitamin D3 and calcipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes. J Invest Dermatol 1993; 101: 706-12.
12. van de Kerkhof PC. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br J Dermatol 1995; 132: 675-82.
13. Thomas MG, Tebbutt S, Williamson RC. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut 1992; 33: 1660-3.
14. Yu J, Papavasiliou V, Rhim J et al. Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia. Anticancer Drugs 1995; 6: 101-8.
15. Katayama H, Kitagawa S, Masuyama J et al. Polymorphonuclear leukocyte-induced detachment of cultured epidermal carcinoma cells from the substratum. J Invest Dermatol 1991; 97: 949-52.
16. Munshi HG, Wu YI, Mukhopadhyay S et al. Differential regulation of membrane type1-matrix metalloproteinase activity by ERK 1 . 2-and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-b1-induced pericellular collagenolysis. J Biol Chem 2004; 279: 39042-50.
17. Mathur RK, Awasthi A, Wadhone P et al. Reciprocal CD40 signals through p38 MAPK and ERK-1 . 2 induce counteracting immune responses. Nat Med 2004; 10: 540-4.
18. Renukaradhya GJ, Webb TJR, Khan MA et al. Virusinduced inhibition of CD1d-mediated antigen presentation: reciprocal regulation by p38 and ERK. J Immunol 2005; 175: 4301-8.
19. Lai WC, Zhou M, Shankavaram U et al. Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1 . 2 mitogenactivated protein kinases. J Immunol 2003; 170: 6244-9.
20. Bahar-Shany K, Ravid A, Koren R. Upregulation of MMP-9 production by TNFalpha in keratinocytes and its attenuation by vitamin D. J Cell Physiol 2010; 222: 729-37.
21. Impola U, Jeskanen L, Ravanti L et al. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds. Br J Dermatol 2005; 152: 720-6.
22. Kivisaari AK, Kallajoki M, Mirtti T et al. Transformationspecific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosaassociated squamous cell carcinomas. Br J Dermatol 2008; 158: 778-85.
23. Cho KH, Son YS, Lee DY et al. Calcipotriol (MC 903), a synthetic derivative of vitamin D3 stimulates differentiation of squamous carcinoma cell line in the raft culture. Anticancer Res 1996; 16: 337-47.
24. Seckin D, Cerman AA, Yildiz A et al. Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report. J Drugs Dermatol 2009; 8: 451-4.